ANDA 215022, held by Sagent Pharms Inc. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 215022 (Succinylcholine Chloride), held by Sagent Pharms Inc, was first approved by FDA on Mar 29, 2021, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 29, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride20MG/ML · injectable;injection | Succinylcholine Chloride | Rx |
| Jan 14, 2025 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jan 14, 2025 | Supplement 2Labeling · Standard review | Approved | None posted |
| Mar 29, 2021 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters